Register for a Live Webcast

A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients

Thursday, April 30, 2020


FACULTY

Joseph Mikhael, MD

Translational Genomics Research Institute

Phoenix, AZ

Kenneth Shain, MD, PhD

Moffitt Cancer Center

Tampa, FL